Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

First Edition: May 16, 2014

First Edition: May 16, 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Concise analysis of global disposable gloves market

Concise analysis of global disposable gloves market

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva's SYNRIBO for injection receives FDA approval for home administration

Cambrex sales decrease by 11.2% in first quarter 2014

Cambrex sales decrease by 11.2% in first quarter 2014

CVS Caremark net revenues increase 6.3% to $32.7 billion in Q1 2014

CVS Caremark net revenues increase 6.3% to $32.7 billion in Q1 2014

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Rite Aid's fourth quarter revenues increase 2.2% to $6.6 billion

Rite Aid's fourth quarter revenues increase 2.2% to $6.6 billion

FDA approves Teva Pharmaceutical's Generic Lovaza Capsules

FDA approves Teva Pharmaceutical's Generic Lovaza Capsules

Walgreens' March sales up 4.5% to $6.43 billion

Walgreens' March sales up 4.5% to $6.43 billion

Viewpoints: 'Thrice-buried' Obamacare 'looks very much alive;' Ted Cruz 'gets an earful'

Viewpoints: 'Thrice-buried' Obamacare 'looks very much alive;' Ted Cruz 'gets an earful'

U.S. Supreme Court agrees to hear Teva Pharmaceutical's appeal related to COPAXONE patent

U.S. Supreme Court agrees to hear Teva Pharmaceutical's appeal related to COPAXONE patent

Viewpoints: Generic drug warnings; Medicare Advantage 'scam'

Viewpoints: Generic drug warnings; Medicare Advantage 'scam'

China Pharma Holdings' revenue decreases 40% to $32.8 million in fiscal year 2013

China Pharma Holdings' revenue decreases 40% to $32.8 million in fiscal year 2013

CPhI to conduct the 4th NEXTGEN China 2014 Conference from March 27 to 28

CPhI to conduct the 4th NEXTGEN China 2014 Conference from March 27 to 28

Teva launches generic Xeloda Tablets in the U.S.

Teva launches generic Xeloda Tablets in the U.S.

Researchers identify communication strategies aimed at creating risk perceptions about generic drugs

Researchers identify communication strategies aimed at creating risk perceptions about generic drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.